Capsaicin protects mice from community-associated methicillin-resistant Staphylococcus aureus pneumonia

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Qiu, Jiazhang ^a   Niu, Xiaodi ^a   Wang, Jianfeng ^a   Xing, Yan ^a   Leng, Bingfeng ^a   Dong, Jing ^a   Li, Hongen ^a   Luo, Mingjing ^a   Zhang, Yu ^a   Dai, Xiaohan ^a   Luo, Yonghuang ^b   Deng, Xuming ^a  

^a JILIN UNIVERSITY   (China)

^b SOUTHWEST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOXIN; CAPSAICIN; CYTOKINE; BACTERIAL TOXIN; HEMOLYSIN; PRIMER DNA; STAPHYLOCOCCAL ALPHA-TOXIN; STAPHYLOCOCCUS ALPHA TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL VIABILITY; CELL VIABILITY; COCULTURE; COMMUNITY ASSOCIATED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; COMMUNITY ASSOCIATED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS PNEUMONIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; HEMOLYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS EPITHELIUM; LUNG INFECTION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MONITORING; MORTALITY; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE DRUG DOSE; STAPHYLOCOCCAL PNEUMONIA; WESTERN BLOTTING; ANIMAL; CELL LINE; COMMUNICABLE DISEASE; DRUG EFFECT; GENETICS; HISTOLOGY; IMMUNOLOGY; LUNG; METABOLISM; PATHOLOGY;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUS; STAPHYLOCOCCUS AUREUS;

ANIMALS; BACTERIAL TOXINS; BLOTTING, WESTERN; CAPSAICIN; CELL LINE; COMMUNITY-ACQUIRED INFECTIONS; CYTOKINES; DNA PRIMERS; HEMOLYSIN PROTEINS; HEMOLYSIS; HISTOLOGICAL TECHNIQUES; HUMANS; LUNG; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; PNEUMONIA, STAPHYLOCOCCAL; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84863232908     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033032     Document Type: Article

References (45)

1. Padmanabhan RA, Fraser TG, (2005) The emergence of methicillin-resistant Staphylococcus aureus in the community. Cleve Clin J Med 72: 235-241.
2. Seybold U, Kourbatova EV, Johnson JG, Halvosa SJ, Wang YF, et al. (2006) Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 42: 647-656.
3. Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, et al. (1998) Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279: 593-598.
4. Kazakova SV, Hageman JC, Matava M, Srinivasan A, Phelan L, et al. (2005) A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 352: 468-475.
5. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, et al. (2003) Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: Worldwide emergence. Emerg Infect Dis 9: 978-984.
6. Li M, Diep BA, Villaruz AE, Braughton KR, Jiang XF, et al. (2009) Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A 106: 5883-5888.
7. Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR, et al. (2006) Is panton-valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 194: 1761-1770.
8. DeLeo FR, Otto M, (2008) An antidote for Staphylococcus aureus pneumonia? J Exp Med 205: 271-274.
9. Bhakdi S, Tranum-Jensen J, (1991) Alpha-toxin of Staphylococcus aureus. Microbiol Rev 55: 733-751.
10. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, et al. (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298: 1763-1771.
11. Athanassa Z, Siempos II, Falagas ME, (2008) Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review. Eur Respir J 31: 625-632.
12. Kuehnert MJ, Hill HA, Kupronis BA, Tokars JI, Solomon SL, et al. (2005) Methicillin-resistant-Staphylococcus aureus hospitalizations, United States. Emerg Infect Dis 11: 868-872.
13. Alksne LE, Projan SJ, (2000) Bacterial virulence as a target for antimicrobial chemotherapy. Curr Opin Biotechnol 11: 625-636.
14. Bubeck Wardenburg J, Schneewind O, (2008) Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med 205: 287-294.
15. Bubeck Wardenburg J, Bae T, Otto M, Deleo FR, Schneewind O, (2007) Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 13: 1405-1406.
16. Bartlett AH, Foster TJ, Hayashida A, Park PW, (2008) Alpha-toxin facilitates the generation of CXC chemokine gradients and stimulates neutrophil homing in Staphylococcus aureus pneumonia. J Infect Dis 198: 1529-1535.
17. Deleo FR, Otto M, Kreiswirth BN, Chambers HF, (2010) Community-associated meticillin-resistant Staphylococcus aureus. Lancet 375: 1557-1568.
18. Novick RP, (2003) Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 48: 1429-1449.
19. Wright JS 3rd, Jin R, Novick RP, (2005) Transient interference with staphylococcal quorum sensing blocks abscess formation. Proc Natl Acad Sci U S A 102: 1691-1696.
20. Shah S, Stapleton PD, Taylor PW, (2008) The polyphenol (-)-epicatechin gallate disrupts the secretion of virulence-related proteins by Staphylococcus aureus. Lett Appl Microbiol 46: 181-185.
21. Qiu J, Wang D, Xiang H, Feng H, Jiang Y, et al. (2010) Subinhibitory concentrations of thymol reduce enterotoxins A and B and alpha-hemolysin production in Staphylococcus aureus isolates. PLoS One 5: e9736.
22. Cichewicz RH, Thorpe PA, (1996) The antimicrobial properties of chile peppers (Capsicum species) and their uses in Mayan medicine. J Ethnopharmacol 52: 61-70.
23. Chatterjee S, Asakura M, Chowdhury N, Neogi SB, Sugimoto N, et al. (2010) Capsaicin, a potential inhibitor of cholera toxin production in Vibrio cholerae. FEMS Microbiol Lett 306: 54-60.
24. Novick RP, Ross HF, Projan SJ, Kornblum J, Kreiswirth B, et al. (1993) Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J 12: 3967-3975.
25. Chan PF, Foster SJ, (1998) Role of SarA in virulence determinant production and environmental signal transduction in Staphylococcus aureus. J Bacteriol 180: 6232-6241.
26. Liang X, Yan M, Ji Y, (2009) The H35A mutated alpha-toxin interferes with cytotoxicity of staphylococcal alpha-toxin. Infect Immun 77: 977-983.
27. Nguyen HM, Graber CJ, (2010) Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer? J Antimicrob Chemother 65: 24-36.
28. Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV, Kollef MH, (2003) Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 124: 1789-1797.
29. Marra A, (2006) Targeting virulence for antibacterial chemotherapy: identifying and characterising virulence factors for lead discovery. Drugs R D 7: 1-16.
30. Cegelski L, Marshall GR, Eldridge GR, Hultgren SJ, (2008) The biology and future prospects of antivirulence therapies. Nat Rev Microbiol 6: 17-27.
31. Escaich S, (2008) Antivirulence as a new antibacterial approach for chemotherapy. Curr Opin Chem Biol 12: 400-408.
32. Rasko DA, Sperandio V, (2010) Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov 9: 117-128.
33. Bramley AJ, Patel AH, O'Reilly M, Foster R, Foster TJ, (1989) Roles of alpha-toxin and beta-toxin in virulence of Staphylococcus aureus for the mouse mammary gland. Infect Immun 57: 2489-2494.
34. Callegan MC, Engel LS, Hill JM, O'Callaghan RJ, (1994) Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis. Infect Immun 62: 2478-2482.
35. Kennedy AD, Bubeck Wardenburg J, Gardner DJ, Long D, Whitney AR, et al. (2010) Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J Infect Dis 202: 1050-1058.
36. Paul M, Leibovici L, (2009) Combination antimicrobial treatment versus monotherapy: the contribution of meta-analyses. Infect Dis Clin North Am 23: 277-293.
37. Stevens DL, Ma Y, Salmi DB, McIndoo E, Wallace RJ, et al. (2007) Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis 195: 202-211.
38. Micek ST, Dunne M, Kollef MH, (2005) Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production. Chest 128: 2732-2738.
39. Abdelnour A, Arvidson S, Bremell T, Ryden C, Tarkowski A, (1993) The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun 61: 3879-3885.
40. Cheung AL, Eberhardt KJ, Chung E, Yeaman MR, Sullam PM, et al. (1994) Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis. J Clin Invest 94: 1815-1822.
41. George EA, Novick RP, Muir TW, (2008) Cyclic peptide inhibitors of staphylococcal virulence prepared by Fmoc-based thiolactone peptide synthesis. J Am Chem Soc 130: 4914-4924.
42. Clinical and Laboratory Standards Institute (2005) Performance standards for antimicrobial susceptibility testing; Fifteenth informational supplement. CLSI/NCCLS document M100-S15. Clinical and Laboratory Standards Institute (CLSI). Wayne, PA.
43. Worlitzsch D, Kaygin H, Steinhuber A, Dalhoff A, Botzenhart K, et al. (2001) Effects of amoxicillin, gentamicin, and moxifloxacin on the hemolytic activity of Staphylococcus aureus in vitro and in vivo. Antimicrob Agents Chemother 45: 196-202.
44. Laemmli UK, (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
45. Sambanthamoorthy K, Smeltzer MS, Elasri MO, (2006) Identification and characterization of msa (SA1233), a gene involved in expression of SarA and several virulence factors in Staphylococcus aureus. Microbiology-Sgm 152: 2559-2572.